Understand your health. Know what to ask.
Fatigue with normal thyroid tests: what has been checked?
Normal thyroid results answer a thyroid question. Persistent fatigue may still need assessment of sleep, medicines, mood or other causes.
4 sources · NIH, Endocrine SocietyRead · 2 min →
Do peptides build muscle? The ingredient and human evidence matter
“Peptide” describes a molecule, not a muscle-building effect. Learn what strength, lean mass and human studies can actually show.
3 sources · FDA, PubMed / PMCRead · 1 min →
CGM, fasting glucose and A1C answer different questions
Continuous glucose trends, a fasting blood sample and A1C show different time windows. How they fit together in a glucose review.
3 sources · FDA, NIHRead · 2 min →
Heartburn during GLP-1 treatment: what to report
Reflux can occur during semaglutide treatment. The timing, severity and accompanying symptoms help a provider assess what is happening.
2 sources · NIHRead · 2 min →
High prolactin and low libido in men
Prolactin can affect sexual function, but an elevated result has several possible causes and may need repeat testing.
Read · 2 min →
TSH and the GLP-1 thyroid warning answer different questions
TSH assesses thyroid function. It does not replace the personal and family history review required by semaglutide and tirzepatide warnings.
3 sources · NIHRead · 2 min →
Night shifts and glucose: what an energy crash can tell you
Night work can affect glucose regulation, but fatigue alone cannot identify high or low blood sugar. Research findings and diagnostic tests differ.
4 sources · PubMed / PMC, NIHRead · 2 min →
Peptides and “reverse aging” claims: what evidence would count?
A biomarker change, early safety study and longer life are different findings. How to assess the evidence behind peptide longevity claims.
4 sources · FDARead · 2 min →
GLP-1 treatment, creatinine and eGFR: reading the change
Kidney results during weight loss need context. Dehydration can matter, while creatinine-based estimates are also influenced by muscle and diet.
4 sources · NIHRead · 2 min →
New bladder urgency around menopause: what gets checked
Urinary urgency can involve bladder problems, infection, medicines and pelvic-floor changes. The pattern helps guide an evaluation.
2 sources · NIHRead · 2 min →
Peptide certificates of analysis: what a COA can verify
A certificate of analysis reports specific batch tests. It does not establish that a research chemical is safe or effective for human use.
3 sources · FDARead · 2 min →
GGT: what this liver test adds to a standard panel
GGT can help interpret other liver tests, particularly an elevated ALP. It is not part of a standard comprehensive metabolic panel.
Read · 2 min →